OXALIPLATIN SUN oxaliplatin 200 mg/40 mL concentrated solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

oxaliplatin sun oxaliplatin 200 mg/40 ml concentrated solution for injection vial

sun pharma anz pty ltd - oxaliplatin, quantity: 200 mg - injection, solution - excipient ingredients: lactose monohydrate; water for injections - oxaliplatin, in combination with fluorouracil and folinic acid, is indicated for: - adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of the primary tumour; - treatment of advanced colorectal cancer

OXALIPLATIN WKT oxaliplatin 100mg/20 ml concentrate for solution for infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

oxaliplatin wkt oxaliplatin 100mg/20 ml concentrate for solution for infusion vial

wockhardt bio pty ltd - oxaliplatin, quantity: 100 mg - injection, concentrated - excipient ingredients: water for injections; nitrogen - oxaliplatin is indicated for adjuvant treatment of stage iii (duke?s c) colon cancer, in combination with fluoropyrimidine agent.,oxaliplatin in combination with fluorouracil and folinic acid is indicated for the treatment of advanced colorectal cancer.,oxaliplatin in combination with capecitabine, with or without bevacizumab, is indicated for the treatment of patients with metastatic colorectal cancer,oxaliplatin in combination with epirubicin and either capecitabine or fluorouracil, is indicated for the treatment of patients with advanced oesophagogastric cancer.

OXALIPLATIN WKT oxaliplatin 50mg/10 mL concentrate for solution for infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

oxaliplatin wkt oxaliplatin 50mg/10 ml concentrate for solution for infusion vial

wockhardt bio pty ltd - oxaliplatin, quantity: 50 mg - injection, concentrated - excipient ingredients: nitrogen; water for injections - oxaliplatin is indicated for adjuvant treatment of stage iii (duke?s c) colon cancer, in combination with fluoropyrimidine agent.,oxaliplatin in combination with fluorouracil and folinic acid is indicated for the treatment of advanced colorectal cancer.,oxaliplatin in combination with capecitabine, with or without bevacizumab, is indicated for the treatment of patients with metastatic colorectal cancer,oxaliplatin in combination with epirubicin and either capecitabine or fluorouracil, is indicated for the treatment of patients with advanced oesophagogastric cancer.

Oxaliplatin Juno oxaliplatin 200mg/40mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

oxaliplatin juno oxaliplatin 200mg/40ml concentrated injection vial

juno pharmaceuticals pty ltd - oxaliplatin, quantity: 200 mg - injection, concentrated - excipient ingredients: water for injections - oxaliplatin is indicated for adjuvant treatment of stage iii (duke?s c) colon cancer, in combination with fluoropyrimidine agent.,oxaliplatin in combination with fluorouracil and folinic acid is indicated for the treatment of advanced colorectal cancer.,oxaliplatin in combination with capecitabine, with or without bevacizumab, is indicated for the treatment of patients with metastatic colorectal cancer.,oxaliplatin in combination with epirubicin and either capecitabine or fluorouracil, is indicated for: the treatment of patients with advanced oesophagogastric cancer

OXALIPLATIN WOCKHARDT oxaliplatin 100mg/20 mL concentrate for solution for infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

oxaliplatin wockhardt oxaliplatin 100mg/20 ml concentrate for solution for infusion vial

wockhardt bio pty ltd - oxaliplatin, quantity: 100 mg - injection, concentrated - excipient ingredients: nitrogen; water for injections - oxaliplatin is indicated for adjuvant treatment of stage iii (duke?s c) colon cancer, in combination with fluoropyrimidine agent.,oxaliplatin in combination with fluorouracil and folinic acid is indicated for the treatment of advanced colorectal cancer.,oxaliplatin in combination with capecitabine, with or without bevacizumab, is indicated for the treatment of patients with metastatic colorectal cancer,oxaliplatin in combination with epirubicin and either capecitabine or fluorouracil, is indicated for the treatment of patients with advanced oesophagogastric cancer.

OXALIPLATIN WOCKHARDT oxaliplatin 50mg/10 mL concentrate for solution for infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

oxaliplatin wockhardt oxaliplatin 50mg/10 ml concentrate for solution for infusion vial

wockhardt bio pty ltd - oxaliplatin, quantity: 50 mg - injection, concentrated - excipient ingredients: nitrogen; water for injections - oxaliplatin is indicated for adjuvant treatment of stage iii (duke?s c) colon cancer, in combination with fluoropyrimidine agent.,oxaliplatin in combination with fluorouracil and folinic acid is indicated for the treatment of advanced colorectal cancer.,oxaliplatin in combination with capecitabine, with or without bevacizumab, is indicated for the treatment of patients with metastatic colorectal cancer,oxaliplatin in combination with epirubicin and either capecitabine or fluorouracil, is indicated for the treatment of patients with advanced oesophagogastric cancer.

OXALIPLATIN SUN oxaliplatin 100 mg/20 mL concentrated solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

oxaliplatin sun oxaliplatin 100 mg/20 ml concentrated solution for injection vial

sun pharma anz pty ltd - oxaliplatin, quantity: 100 mg - injection, solution - excipient ingredients: water for injections; lactose monohydrate - oxaliplatin, in combination with fluorouracil and folinic acid, is indicated for: - adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of the primary tumour; - treatment of advanced colorectal cancer

OXALIPLATIN SUN oxaliplatin 50mg/10mL concentrated solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

oxaliplatin sun oxaliplatin 50mg/10ml concentrated solution for injection vial

sun pharma anz pty ltd - oxaliplatin, quantity: 50 mg - injection, solution - excipient ingredients: lactose monohydrate; water for injections - oxaliplatin, in combination with fluorouracil and folinic acid, is indicated for: - adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of the primary tumour; - treatment of advanced colorectal cancer

OXALIPLATIN ACCORD oxaliplatin 100 mg/20 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

oxaliplatin accord oxaliplatin 100 mg/20 ml concentrated injection vial

accord healthcare pty ltd - oxaliplatin, quantity: 100 mg - injection, concentrated - excipient ingredients: water for injections; lactose monohydrate - oxaliplatin, in combination with fluorouracil and folinic acid, is indicated for: adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of the primary tumour; treatment of advanced colorectal cancer.

OXALIPLATIN ACCORD oxaliplatin 50 mg/10 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

oxaliplatin accord oxaliplatin 50 mg/10 ml concentrated injection vial

accord healthcare pty ltd - oxaliplatin, quantity: 50 mg - injection, concentrated - excipient ingredients: water for injections; lactose monohydrate - oxaliplatin, in combination with fluorouracil and folinic acid, is indicated for: adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of the primary tumour; treatment of advanced colorectal cancer.